medmix AG (MEDX) — Capital Reinvestment Ratio
medmix AG (MEDX) has a Capital Reinvestment Ratio of 0.50x as of December 2025, meaning it reinvests 1% of its operating cash flow (CHF37.40 Million) in capital expenditures (CHF18.80 Million). See medmix AG balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
medmix AG Capital Reinvestment Ratio (2018–2025)
This chart tracks medmix AG's Capital Reinvestment Ratio across 8 annual periods. Check MEDX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for medmix AG (2018–2025)
Year-by-year Capital Reinvestment Ratio for medmix AG from 2018 to 2025. For live market cap and broader valuation context, see medmix AG market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.51x | CHF67.80 Million | CHF34.50 Million | ▼ -9.1% |
| 2024 | 0.56x | CHF86.60 Million | CHF48.50 Million | ▼ -40.6% |
| 2023 | 0.94x | CHF56.10 Million | CHF52.90 Million | ▲ +16.3% |
| 2022 | 0.81x | CHF47.60 Million | CHF38.60 Million | ▲ +121.9% |
| 2021 | 0.37x | CHF87.30 Million | CHF31.90 Million | ▼ -57.1% |
| 2020 | 0.85x | CHF50.60 Million | CHF43.10 Million | ▲ +109.7% |
| 2019 | 0.41x | CHF89.10 Million | CHF36.20 Million | ▲ +27.6% |
| 2018 | 0.32x | CHF94.20 Million | CHF30.00 Million | — |